Everolimus
analytical standard
Manufacturer: Supelco
CAS Number: 159351-69-6
Synonym(S): 42-O-(2-Hydroxyethyl)rapamycin
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 10 MG | 94687-10-MG | In Stock | ₹ 18,261.78 |
94687 - 10 MG
In Stock
Quantity
1
Base Price: ₹ 18,261.78
GST (18%): ₹ 3,287.12
Total Price: ₹ 21,548.90
grade
analytical standard
Quality Level
100
Assay
≥75.0% (qNMR)
shelf life
limited shelf life, expiry date on the label
application(s)
clinical testing
format
neat
storage temp.
−20°C
SMILES string
O=C(C([C@@]1(O)[C@H](C)CC[C@](C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C2=O)([H])O1)=O)N3[C@H](C(O[C@@]([C@@H](C[C@@]4([H])C[C@@H](OC)[C@H](OCCO)CC4)C)([H])CC([C@H](C)/C=C(C)/[C@@H](O)[C@H]2OC)=O)=O)CCCC3
InChI
1S/C53H83NO14/c1-32-16-12-11-13-17-33(2)44(63-8)30-40-21-19-38(7)53(62,68-40)50(59)51(60)54-23-15-14-18-41(54)52(61)67-45(35(4)28-39-20-22-43(66-25-24-55)46(29-39)64-9)31-42(56)34(3)27-37(6)48(58)49(65-10)47(57)36(5)26-32/h11-13,16-17,27,32,34-36,38-41,43-46,48-49,55,58,62H,14-15,18-26,28-31H2,1-10H3/b13-11+,16-12+,33-17+,37-27+/t32-,34-,35-,36-,38-,39+,40+,41+,43-,44+,45+,46-,48-,49+,53-/m1/s1
InChI key
HKVAMNSJSFKALM-GKUWKFKPSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
eMolecules Everolimus | 159351-69-6 | MFCD00929329 | 5mg | -- | ₹ 6,550.40 | ||
Selleck Chemical LLC Everolimus (RAD001) 10mM/1mL 159351-69-6 | -- | ₹ 23,496.00 | ||
Everolimus Analytical Standard, MilliporeSigma™ Supelco™ | -- | ₹ 20,826.00 | ||
Sigma Aldrich Fine Chemicals Biosciences Everolimus >=95% (HPLC) | 159351-69-6 | MFCD00929329 | 50MG | -- | ₹ 56,390.40 | ||
Sigma Aldrich Fine Chemicals Biosciences Everolimus | 159351-69-6 | MFCD00929329 | 10 mg | -- | ₹ 14,391.30 | ||
Selleck Chemical LLC Everolimus (RAD001) 100mg 159351-69-6 | -- | ₹ 69,170.80 | ||
Apexbio Technology LLC Everolimus (RAD001), 10mg. Cas: 159351-69-6 MFCD: MFCD00929329. MTOR inhibitor | -- | ₹ 6,230.00 | ||
Everolimus | -- | ₹ 47,240.30 | ||
Everolimus for impurity C identification | -- | ₹ 15,880.28 | ||
Everolimus solution | -- | ₹ 32,944.10 |
Description
- General description: Everolimus (RAD001), a derivative of rapamycin,[1] is commonly used as a drug for the inhibition of the mTOR pathway, affecting tumor cell division and angiogenesis.[2]
- Application: Everolimus may be used as a standard in the following clinical studies: Investigation of its glucose-dependent growth-inhibitory property in breast cancer cell lines.[3] Evaluate its possible antiproliferative effects in human bronchial carcinoids in primary culture.[4]
SAFETY INFORMATION
Pictograms
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Aquatic Acute 1 - Aquatic Chronic 1 - Carc. 2 - Repr. 2 - STOT RE 2
Target Organs
Kidney,Testes
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable